Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World

Article Ophthalmology

Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report

Amirreza Veisi et al.

Summary: This report presents two cases of COVID-19 patients treated with corticosteroid developing mucormycosis, emphasizing the importance of prompt diagnosis and management.

EUROPEAN JOURNAL OF OPHTHALMOLOGY (2022)

Add to Collection

Article Ophthalmology

Secondary infection with rhino-orbital cerebral mucormycosis associated with COVID-19

Liane O. Dallalzadeh et al.

Summary: Two fatal cases of rhino-orbital-cerebral mucormycosis associated with COVID-19 infection were reported, both rapidly declining and extending into the intracranial cavity. The role of ophthalmologists is crucial in early diagnosis of COVID-19 related mucormycosis.

ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY (2022)

Add to Collection

Article Otorhinolaryngology

Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum

S. Sharma et al.

Summary: A study found an association between coronavirus disease and fungal infection of the paranasal sinuses, with ethmoids being the most commonly affected sinuses. Intra-orbital extension occurred in 43.47% of cases, while intracranial extension was seen in only 8.69% of cases. Twenty-one out of 23 patients had diabetes mellitus, with 12 cases being uncontrolled, and all patients had a history of steroid use during their coronavirus treatment.

JOURNAL OF LARYNGOLOGY AND OTOLOGY (2021)

Add to Collection

Article Respiratory System